In this issue:
Triage tool for identifying patients eligible for advanced HF centre referral
Empagliflozin improves outcomes in HFPEF irrespective of age
Sacubitril/valsartan tolerability in advanced HF
ARNI outcomes in HFREF according to race/ethnicity
Postoperative AF and HF hospitalisation risk
Haemodynamic effects of mirabegron, a β3-adrenoceptor agonist, in advanced HF
Right HF following LVAD implantation
Vericiguat and health-related QOL in HFREF
Diuresis/kidney function after early empagliflozin initiation in acute decompensated HF
Short-term effects of dapagliflozin on maximal functional capacity in HFREF
Please login below to download this issue (PDF)